510(k) Report

510(k) · Cleared

Cleared

Scanscope XT System

K080564510(k) TraditionalCleared Aug 14, 2009533-day reviewClass II21 CFR 864.1860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aperio Technologies · NOT Microscope, Automated, Image Analysis, Operator Intervention

Cleared on Aug 14, 2009 as substantially equivalent to K032113 (Chroma Vision Medical Systems, Inc., 2003) and 1 other predicate after a 533-day review. Its family tree reaches back 1 generation to 2003. 3 later devices descend from it.

Decided
Aug 14, 2009
Review
533 days
Class
Class II
Product code
NOT
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K032113 (2003). 2 ancestors in all. 3 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor2011: 1 descendant cleared2014: 1 descendant cleared2015: 1 descendant clearedK032113 · Acis (Automated Cellular Imaging System) · Chroma Vision Medical Systems, Inc. · 2003200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 2 descendants K032113 · Acis (Automated Cellular Imaging System) · Chroma Vision Medical Systems, Inc. · 20030
  1. Root · 1 generation backK032113 Acis (Automated Cellular Imaging System)Chroma Vision Medical Systems, Inc. · 2003
  2. This deviceK080564 Scanscope XT SystemAperio Technologies · 2009
  3. Descendant · cites it directly · 2 of its ownK111543 Virtuoso (TM) System for Ihc HER2 (4B5)Ventana Medical Systems, Inc. · 2011
  4. Descendant · 2 generations on · 0 of its ownK140957 Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd. · 2015
  5. Descendant · 2 generations on · 0 of its ownK131140 Omnyx Idp for HER2 Manual ApplicationOmnyx, LLC · 2014

Most influential descendants

Showing 3 of 3 · See all
  • K111543Virtuoso (TM) System for Ihc HER2 (4B5)Ventana Medical Systems, Inc. · 2011 · cites it directly2descendants
  • K140957Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd. · 2015 · 2 generations on0descendants
  • K131140Omnyx Idp for HER2 Manual ApplicationOmnyx, LLC · 2014 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K032113Acis (Automated Cellular Imaging System)Chroma Vision Medical Systems, Inc.2003—
0 (this device)K080564Scanscope XT SystemAperio Technologies2009—
+1K111543Virtuoso (TM) System for Ihc HER2 (4B5)Ventana Medical Systems, Inc.2011—
+2K140957Genasis Hipath Ihc FamilyApplied Spectral Imaging, Ltd.2015—
+2K131140Omnyx Idp for HER2 Manual ApplicationOmnyx, LLC2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
201410
201510
FIG. 1 — Lineage of K080564, 2003–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NOT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NOT device

  1. #1 K260755 OptraSCAN Systemscore 12.2 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032113Acis (Automated Cellular Imaging System)
Summary page 2
…510(k) Summary- ScanScope® XT System -RevJune 09 Page 1 of 7 a aperio Predicate Device K#: K032113 Predicate Device #2: Applied Imaging Ariol T M with HER2 Application Manufacturer: Appli…
Chroma Vision Medical Systems, Inc.2003—
*K031715Ariol Her-2/Neu Ihc
Summary page 2
…e #2: Applied Imaging Ariol T M with HER2 Application Manufacturer: Applied Imaging Corporation Predicate Device K#: K031715 21 CFR 807.92(a)(4): Description of the device that is the subject of this pre-market notification: System.' The ScanS…
Applied Imaging Corp.20041

Also cleared against K032113: 3 other devices →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K111543Virtuoso (TM) System for Ihc HER2 (4B5)Ventana Medical Systems, Inc.20112

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K111543 (Ventana Medical Systems, Inc., 2011) has gone furthest, with 2 descendants of its own.
  • 3 other devices also cite its predicate K032113.

How does its category compare?

All NOT devices

NOT Microscope, Automated, Image Analysis, Operator Intervention: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · NOT

1in 2014

2007: 22009: 22011: 12012: 22013: 12014: 12026 (partial year): 1
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NOT

Too few NOT 510(k)s in any year since 2007 to give a median.

Recalls per year · NOT

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NOT

1in 2023

2014: 12015: 12023: 1
2007high 1 (2014) · low 0 (2007)2025

MAUDE reports naming product code NOT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20080—00
20092—00
20100—00
20111—00
20122—00
20131—00
20141—01
20150—01
20160—00
20170—00
20180—10
20190—00
20200—00
20210—00
20220—00
20230—01
20240—00
20250—00
20261—0—

What is it indicated for?

The ScanScope System is an automated digital slide creation, management, viewing and analysis system. It is intended for in vitro diagnostic use as an aid to the pathologist in the display, detection, counting and classification of tissues and cells of clinical interest based on particular color, intensity, size, pattern and shape. The IHC HER2 Breast Tissue Tunable Image Analysis application is intended for use as an aid to the pathologist in the…

Read the full statement (263 words)

The ScanScope System is an automated digital slide creation, management, viewing and analysis system. It is intended for in vitro diagnostic use as an aid to the pathologist in the display, detection, counting and classification of tissues and cells of clinical interest based on particular color, intensity, size, pattern and shape.

The IHC HER2 Breast Tissue Tunable Image Analysis application is intended for use as an aid to the pathologist in the detection and semi-quantitative measurement of HER2/neu (c-erbB-2) in formalin-fixed, paraffin-embedded normal and neoplastic tissue.

The IHC HER2 Breast Tissue Tunable Image Analysis application is intended for use as an accessory to the Dako HercepTestTM to aid in the detection and semi-quantitative measurement of HER2/neu (c-erbB-2) in formalin-fixed, paraffin-embedded normal and neoplastic tissue. It is indicated for use as an aid in the assessment of breast cancer patients for whom HERCEPTIN® (Trastuzumab) treatment is being considered. Note: The IHC HER2 Breast Tissue Tunable Image Analysis application is an adjunctive computer-assisted methodology to assist the reproducibility of a qualified pathologist in the acquisition and measurement of images from microscope slides of breast cancer specimens stained for the presence of HER2 receptor protein. The accuracy of the test result depends upon the quality of the immunohistochemical staining. It is the responsibility of a qualified pathologist to employ appropriate morphological studies and controls as specified in the instructions for the HER2 reagent/kit used to assure the validity of the IHC HER2 Breast Tissue Tunable Image Analysis application assisted HER2/neu score. The actual correlation of the HER2 reagents/kits to Herceptin® clinical outcome has not been established.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K080564: Scanscope XT System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K080564

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026